Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study

Summary Chronic myelomonocytic leukemia (CMML) is a rare and aggressive myeloid malignancy with overlapped features of myelodysplastic syndromes/myeloproliferative neoplasms. Azacitidine (AZA), a hypomethylating agent, has been approved for the treatment of CMML in China, but real-world data are lim...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Xu, Yu [verfasserIn]

Guo, Rong

Miao, Miao

Zhang, Guangsen

Lan, Jianping

Jin, Jie

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Schlagwörter:

Chronic myelomonocytic leukemia

Hypomethylating agents

Azacitidine

Efficacy

Tolerability

Anmerkung:

© The Author(s) 2022

Übergeordnetes Werk:

Enthalten in: Investigational new drugs - Dordrecht [u.a.] : Springer Science + Business Media B.V, 1983, 40(2022), 5 vom: 14. Juli, Seite 1117-1124

Übergeordnetes Werk:

volume:40 ; year:2022 ; number:5 ; day:14 ; month:07 ; pages:1117-1124

Links:

Volltext

DOI / URN:

10.1007/s10637-022-01283-x

Katalog-ID:

SPR047907207

Nicht das Richtige dabei?

Schreiben Sie uns!